SER vs SO · rev $56.0K vs P/E 22, rev $29.55B
Serina Therapeutics Inc (SER) versus Southern Company (SO) — a side-by-side from cached financials, not a winner call.
Serina Therapeutics Inc (SER) is a biotechnology company listed on AMEX.
Southern Company (SO) is a utilities - regulated electric company listed on US.
Latest reported SER revenue for 2024-12-31 was $56.0K. Net income was -$11.2M. Revenue was down 98.2% from 2023-12-31 to 2024-12-31. SER currently screens at market cap $29.7M.
Latest reported SO revenue for 2025-12-31 was $29.55B. Net income was $4.34B. Revenue was up 10.6% from 2024-12-31 to 2025-12-31. SO currently screens at market cap $101.55B and trailing P/E 22.1.
SER currently screens at market cap $29.7M. SO currently screens at market cap $101.55B and trailing P/E 22.1.
Not investment advice. Open the SER and SO stock pages for the full models.
Not investment advice.